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Abstract
Corynebacterium 2,5-Diketo-D-gluconic acid reductase (2,5-DKGR) catalyzes the reduction of 2,5-diketo-
D-gluconic acid (2,5-DKG) to 2-Keto-L-gulonic acid (2-KLG). 2-KLG is an immediate precursor to L-
ascorbic acid (vitamin C), and 2,5-DKGR is, therefore, an important enzyme in a novel industrial method
for the production of vitamin C. 2,5-DKGR, as with most other members of the aldo-keto reductase (AKR)
superfamily, exhibits a preference for NADPH compared to NADH as a cofactor in the stereo-specific
reduction of substrate. The application of 2,5-DKGR in the industrial production of vitamin C would be
greatly enhanced if NADH could be efficiently utilized as a cofactor. A mutant form of 2,5-DKGR has
previously been identified that exhibits two orders of magnitude higher activity with NADH in comparison
to the wild-type enzyme, while retaining a high level of activity with NADPH. We report here an X-ray
crystal structure of the holo form of this mutant in complex with NADH cofactor, as well as thermodynamic
stability data. By comparing the results to our previously reported X-ray structure of the holo form of
wild-type 2,5-DKGR in complex with NADPH, the structural basis of the differential NAD(P)H selectivity
of wild-type and mutant 2,5-DKGR enzymes has been identified.
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Between 10 and 40 million years ago, the common ancestor
of the great apes suffered a catastrophic mutation in the
gene for L-gulonolactone oxidase—the last enzyme in the
biosynthetic pathway for L-ascorbate. Since that event, L-
ascorbate has been an essential dietary nutrient (vitamin C)
for all great apes, including man. Application as an antioxi-
dant and preservative in the food and beverage industry, in
addition to dietary supplements, has resulted in a current
worldwide consumption of vitamin C in excess of 50,000
tons per year (Banta et al. 2002b), making vitamin C one of
the most important specialty chemicals in the world.
Vitamin C is currently produced from D-glucose using a
modified Reichstein–Grussner synthesis, devised by the
Nobel Prize winning chemist Thaddeus Reichstein (Reich-
stein and Grussner 1934), and involving five chemical steps
and a single fermentation step. The penultimate intermedi-
ate in this process, 2-keto-L-gulonic acid (2-KLG), is a rela-
tively stable compound that can be stored for later conver-
sion (via acid or base cyclization) to L-ascorbate. A long-
standing goal has been the development of a new method
for the production of vitamin C that replaces the chemical
steps with direct fermentation of D-glucose to 2-KLG. In
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the early 1980s Sonoyama and coworkers identified a strain
of Erwinia herbicola capable of fermenting D-glucose to
2,5-diketo-D-gluconate (2,5-DKG; an intermediate that is
not part of the Reichstein–Grussner synthesis), and a strain
of Corynebacterium able to subsequently ferment 2,5-DKG
to 2-KLG (Sonoyama et al. 1982). The two fermentation
steps were combined in tandem to produce 2-KLG (and thus
L-ascorbate) from D-glucose with effective elimination of
intermediate chemical steps. The fermentation of 2,5-DKG
to 2-KLG by the Corynebacterium was identified as the
product of a single catalytic step involving the NADPH-
dependent enzyme 2,5-diketo-D-gluconate reductase (2,5-
DKGR). Two distinct forms of 2,5-DKGR, types “A” and
“B,” were characterized (Sonoyama and Kobayashi 1987)
and identified as members of the aldo-keto reductase (AKR)
family that share a characteristic TIM barrel tertiary struc-
ture and non–Rossman-fold nucleotide-binding domain.
Subsequently, Anderson and coworkers introduced the gene
for 2,5-DKGR “A” (2,5-DKGRA) into Erwinia herbicola to
develop a genetically engineered strain capable of direct
fermentation of 2-KLG from D-glucose (Anderson et al.
1985). A further simplification of the fermentation of
2-KLG from D-glucose has been developed by utilizing
permeabilized Pantoea citrea cells (that can convert D-glu-
cose to 2,5-DKG via membrane-bound dehydrogenases) in
a bioreactor scheme utilizing exogenously added 2,5-
DKGR enzyme, NADP+, and a soluble NADP+-dependent
glucose dehydrogenase (Boston and Swanson 2003). In this
method, the NADP+ is recycled by the action of the two
exogenously added enzymes.
Being a commodity item of an industrial process, the cost
associated with production of vitamin C is of paramount
importance. Although the above-described methodologies
can produce vitamin C, their ability to compete in cost with
the existing method remains to be proven. The typical cell
concentration of NADH is approximately threefold higher
than NADPH (Lundquist and Olivera 1971). Thus, in fer-
mentation-based production methods, NADH would be the
more abundant cofactor. NADH is also commercially less
expensive than NADPH (by approximately an order of mag-
nitude) and is more stable than NADPH. Thus, NADH is
also preferred for exogenously added cofactor in the biore-
actor scheme of Boston and Swanson. However, the disso-
ciation constant for NADH with 2,5-DKGRA is
2.6 × 10−3M (Banta et al. 2002b) whereas it is approxi-
mately 10 × 10−6M with NADPH (Miller et al. 1987;
Sonoyama and Kobayashi 1987; Powers 1996). In light of
the above considerations, Anderson and coworkers have
argued that a significant enhancement could be achieved if
the 2,5-DKGR enzyme could be engineered to function us-
ing NADH as a cofactor instead of NADPH (Banta et al.
2002b). Recent work involving a series of directed and com-
binatorial mutagenesis experiments has identified a mutant
form of the enzyme (K232G, R238H; we will refer to mu-
tations using the single letter code, thus K232G refers to a
Lys 232 → Gly point mutation) with an almost threefold
reduction in the dissociation constant for NADH in addition
to a sevenfold increase in overall kcat using NADH as co-
factor (Powers 1996; Banta and Anderson 2002; Banta et al.
2002b,c). This double mutant has been combined with ad-
ditional substrate binding site mutations (F22Y, A272G)
resulting in a quadruple mutant exhibiting the lowest dis-
sociation constant (6.6 × 10−4M) for NADH identified to date
(Banta et al. 2002c). Furthermore, mathematical modeling
of 2-KLG production suggests that the use of the F22Y/
K232G/R238H/A272G 2,5-DKGRA mutant with NAD(H),
in combination with a small amount of NADP(H), could
provide a significant cost benefit for in vitro enzymatic
production of 2-KLG (Banta et al. 2002a).
The Corynebacterium from which 2,5-DKGRA and 2,5-
DKGRB have been isolated is a soil-dwelling bacterium
with a growth optimum of approximately 22°C. Irreversible
thermal denaturation studies, monitoring unfolding by cir-
cular dichroism (CD), indicate a melting transition midpoint
of approximately 38°C for 2,5-DKGRA and 32°C for 2,5-
DKGRB (Powers 1996). Thus, although the stability of ei-
ther form is appropriate for the normal growth temperature,
it is problematic for the higher fermentation temperatures
more typical of enteric bacteria (37°C). At such higher tem-
peratures, an increase in the apparent kcat value could, there-
fore, also be achieved by thermal stabilization of the en-
zyme. Furthermore, the low thermal stability limits the abil-
ity to freely mutagenize the protein, as several potentially
interesting activity site mutations have proven to be too
destabilized to isolate (Powers 1996).
We report here the 2.0 Å X-ray structure determination,
and isothermal equilibrium denaturation characterization, of
a quadruple mutant (F22Y/K232G/R238H/A272G) of Cory-
nebacterium 2,5-DKGRA in complex with NADH. In con-
junction with our previously reported X-ray structure of
wild-type 2,5-DKGRA in complex with NADPH, we are
able to elucidate the details of the structural basis of the
improved dissociation constant with NADH cofactor. The
results show how this mutation is able to enhance binding to
NADH, while retaining to a large extent the ability to bind
NADPH. Furthermore, the thermodynamic data show that
this quadruple mutant is also stabilized in relationship to the
wild-type protein; thus, this mutant form is ideally suited for
function at higher temperatures associated with industrial
fermentation or bioreactor processes, or as a background for
further mutagenic studies.
Results
Crystal data, processing, and refinement statistics for the
F22Y/K232G/R238H/A272G 2,5-DKGRA mutant in com-
plex with NADH are listed in Table 1. The space group was
identified as C2 with one molecule per asymmetric unit.
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This is a different space group in comparison to the wild-
type apo enzyme (no cofactor; space group, P212121; PDB
accession number 1HW6) and wild-type holo enzyme (with
NADPH; space group, P21; PDB accession number 1A80)
X-ray structures (Khurana et al. 1998; Sanli and Blaber
2001). The crystals of the mutant 2,5-DKGRA were some-
what radiation sensitive, and the image plate and CCD data
sets were therefore combined to achieve maximum com-
pleteness while retaining an acceptable value for Rmerge
(Table 1). The Wilson temperature factor for the mutant
data set is essentially identical to the P21 crystal form of the
cofactor-bound form of wild-type 2,5-DKGRA. Final model
building and refinement resulted in excellent stereochemis-
try and crystallographic residual (Table 1). Analysis of the
Ramachandran plot distribution indicates that 90.3% of the
residue positions are located in the most favored regions,
with no residues in disallowed regions. Unambiguous den-
sity within the active site indicated that the NADH cofactor
added to the protein solution during crystallization was
bound within the active site. We note that although the
cofactor was added to the crystallization solution as the
reduced form, the crystallographic data cannot distinguish
between oxidized and reduced forms. Thus, the bound co-
factor may be present as the oxidized (NAD+) form.
The overall structure of the mutant 2,5-DKGRA follows
closely that of the wild-type 2,5-DKGRA/NADPH holo
structure (Khurana et al. 1998), and the main chain atoms of
both structures overlay with a root mean square (r.m.s.)
deviation of 0.43 Å. However, if the first five residues are
excluded from the overlay, the r.m.s. deviation improves to
0.38 Å. Thus, the mutations have been accommodated with
minimal overall structural perturbation. Similarly, the
NADH cofactor in the mutant structure overlays the
NADPH cofactor from the holo wild-type structure (sans
the 2 phosphate moiety) with an r.m.s. deviation of 0.35 Å.
Thus, the NAD cofactor is bound within the mutant struc-
ture with minimal structural perturbation.
A detailed description of the interactions between
NADPH cofactor in the holo wild-type structure has previ-
ously been described (Khurana et al. 1998). Briefly, the
interactions comprise a total of 16 hydrogen bonds, 2 ionic
bonds, and 1 aromatic stacking interaction with the nicotin-
amide ring. Of these interactions, those directly interacting
with the 2 phosphate of the NADPH cofactor include Lys
232 N, Val 234 N, Ser 233 O, and Arg 238 N1. The Lys
232 N interaction is eliminated with the K232G mutation,
and the Arg238 N1 interaction is similarly eliminated with
the R238H mutation. However, the structure of the mutant
2,5-DKGRA with bound NADH shows that the introduced
His side chain at position 238 introduces a novel base-
stacking interaction with the adenine ring of the NADH
cofactor (Fig. 1). The Ser side chain at position 233 has not
been subject to mutation; however, in response to the lack of
a 2 phosphate moiety in the bound NADH, this side chain
has adopted an alternative rotamer that positions the O
away from the cofactor binding site (Fig. 1). Finally, the
main chain amide of position 234 remains available for
hydrogen bonding with a cofactor 2 phosphate, and the
main chain conformation at this position is essentially un-
changed in the mutant 2,5-DKGRA (Fig. 1).
Table 1. Crystal, data collection, and refinement statistics for
F22Y/K232G/R238H/A272G 2,5-DKGRA in complex with NADH
Crystal data
Space group C2
Cell constants a  111.95 Å, b  55.24 Å,
c  51.54 Å,   111.7°
Molecules/asymmetric unit 1
Matthews coefficient (Vm) Å3/D 2.2
Resolution range (Å) 27.0–2.0
Data collection and processing
Total/unique reflections 242,073/18,364
Completion (%; 27.0–2.0 Å) 92.9
Completion (%; 2.05–2.0 Å) 83.3
I/ (overall) 16.6
I/ (2.05–2.0 Å) 4.2
Rmerge (%) 11.4
Wilson temperature factor (Å2) 15.0
Refinement
Rcryst (%; 27.0–2.0 Å) 21.4
Rfree (%; 27.0–2.0 Å) 26.1
R.m.s. bond length deviation (Å) 0.008
R.m.s. bond angle deviation (°) 1.5
R.m.s. B factor deviation ()a 2.1
a Library of Tronrud (Tronrud 1996).
Figure 1. Relaxed stereo diagram of the overlay of F22Y/K232G/R238H/
A272G 2,5-DKGRA (dark gray) with wild type (1A80; light gray). The
view is toward the adenine of the bound NADPH/NADH cofactor and
provides structural details of the region involving the K232G and R238H
mutations. The hydrogen bonding interactions of the 2 adenosine phos-
phate group (of the NADPH bound in the wild-type structure) are indi-
cated.
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Mutation F22Y is located within the substrate-binding
site, and is approximately 13 Å distal to the location of the
NADPH 2 phosphate position (Khurana et al. 1998). Simi-
larly, the A272G mutation is approximately 21 Å distal. The
introduced Tyr side chain at position 22 adopts an identical
rotamer to the wild-type Phe residue (Fig. 2). The A272G
mutation is accommodated with little, if any, structural per-
turbation (Fig. 2).
The isothermal equilibrium denaturation data for both
wild-type and mutant 2,5-DKGRA exhibited excellent
agreement with the two-state denaturation model. The G
of unfolding for wild-type 2,5-DKGRA is 33.5 kJ/mole un-
der conditions of 0 M denaturant (G0; Table 2). The G of
unfolding for the mutant 2,5-DKGRA is 36.4 kJ/mole in 0
M denaturant. The isothermal equilibrium denaturation m
values are slightly different for the two proteins, with the
mutant exhibiting moderately reduced cooperativity. In
such cases, a comparison of the extrapolated G0 values is
less accurate than a comparison at the midpoint of denatur-
ation (i.e., G0  0; Pace and Scholtz 1997). The mutation
increases the midpoint of denaturation by 0.16 M GuHCl
(Fig. 3), corresponding to an increase in stability (G) of
5.2 kJ/mole (Table 2).
Discussion
Corynebacterium expresses two distinct variants of 2,5-
DKGR, form “A” and form “B,” that are the products of
distinctly different genes (Sonoyama and Kobayashi 1987).
The two forms share 38% amino acid identity and different
biophysical and enzymatic properties. With regard to bio-
physical properties, as previously mentioned, 2,5-DKGRA
exhibits a higher melting temperature than 2,5-DKGRB.
With regard to enzymatic properties, 2,5-DKGRA follows
Michaelis–Menten kinetics, with a Km of 31 mM and kcat of
8.34 sec−1, with 2,5-DKG as substrate (Miller et al. 1987;
Powers 1996). Conversely, 2,5-DKGRB exhibits a Km of
2.26 mM and kcat 18.8 sec−1 with 2,5-DKG as substrate, but
exhibits pronounced substrate inhibition at concentrations
higher than 10 mM (Powers 1996). Thus, 2,5-DKGRA is
more stable than 2,5-DKGRB, and is not inhibited by high
substrate concentrations, but is generally less active. In an
attempt to incorporate the favorable activity properties of
2,5-DKGRB into the more stable 2,5-DKGRA, Powers
(1996) constructed a series of chimeric and scanning muta-
tions involving both forms. These studies identified a cru-
cial role for a Tyr side chain at position 22 (F22Y mutation
in 2,5-DKGRA) in both reducing Km (to ∼10 mM) and
increasing kcat (by ∼50%). Additionally, a Gly mutation at
position 272 (A272G in 2,5-DKGRA) resulted in a twofold
increase in kcat, but also an increase in Km (to ∼43mM). The
2,5-DKGRA double mutant (F22Y/A272G) exhibited addi-
tive effects upon the kinetic properties of the individual
mutations, and surpassed the activity of 2,5-DKGRB at sub-
strate concentrations greater than 17.5 mM (although it did
exhibit some substrate inhibition; Powers 1996).
Molecular modeling studies of substrate binding (utiliz-
ing the holo wild-type 2,5-DKGRA X-ray structure; 1A80),
suggested that the introduced Tyr residue at position 22
would be adopted with minimal perturbation of the structure
(Khurana et al. 2000). Furthermore, it was proposed that if
the introduced Tyr residue adopted the same rotamer as the
wild-type Phe residue, the side chain hydroxyl would be
positioned to hydrogen bond with the 2,5-DKG substrate C1
carboxyl group (Khurana et al. 2000). The structure of the
F22Y/K232G/R238H/A272G 2,5-DKGRA mutant reported
Figure 2. Relaxed stereo diagram of the overlay of F22Y/K232G/R238H/A272G 2,5-DKGRA (dark gray) with wild type (1A80; light
gray). The view is oriented toward the substrate-binding pocket (Khurana et al. 1998, 2000) and provides structural details of the region
involving the F22Y and A272G mutations. The orientation of the NAD(P)H cofactor is identical to Figure 1.
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here shows that the introduced Tyr side chain at position 22
is adopted with minimal perturbation of the structure and
assumes the same rotamer as the wild-type Phe residue (Fig.
2). Thus, the hypothesized basis for the improved kinetic
constants with this mutation (primarily a reduction in Km) is
supported by the present structural data.
No similar hypothesis for the basis of the improved cata-
lytic effects of the A272G mutation in 2,5-DKGRA have
been proposed. However, its location within the carboxyl-
terminal region, and the role of this region in forming a lip
of the substrate binding pocket, suggest that an Ala → Gly
mutation could affect either access of substrate to the bind-
ing pocket or the shape of the pocket (Powers 1996). A
structural determination of the apo 2,5-DKGRA indicated
that cofactor binding is associated with substantial structural
changes, including ordering of the carboxyl terminal region
involving residues 264–278 (Sanli and Blaber 2001). The
structural details of the F22Y/K232G/R238H/A272G 2,5-
DKGRA mutant reported here show that the A272G muta-
tion is not associated with significant structural changes of
the local region (Fig. 2). Thus, the A272G mutation most
likely improves the kinetic properties by either promoting
access of substrate or possibly increasing the kinetics asso-
ciated with binding pocket formation upon cofactor binding
or, conversely, cofactor release. Further studies will be re-
quired to resolve this question.
The Lys residue at position 232 is known to be one of
four residue positions in 2,5-DKGRA that interact directly
with the 2 phosphate group of the bound NADPH cofactor
(Khurana et al. 1998). A study of various mutations at this
position, involving chemically and structurally different
amino acids, and screening for activity with NADH cofac-
tor, indicated that a Gly substitution resulted in a slight
reduction in cofactor Ka and a slight increase in overall kcat
(albeit with a significant reduction in activity using NADPH
cofactor; Banta et al. 2002b). The structural details of the
F22Y/K232G/R238H/A272G 2,5-DKGRA mutant reported
here show that the Gly mutation at position 232 results in
little, if any, structural perturbation (Fig. 1). The primary
effect of this mutation appears to be the elimination of a
potential electrostatic interaction between the Lys N and
NADPH. With the exception of possible increased access to
the cofactor-binding site, there appears to be little selective
advantage for NADH binding afforded by this mutation.
The Arg side chain at position 238 is known to form a
direct electrostatic interaction with the 2 phosphate of
bound NADPH (Khurana et al. 1998), and mutation by His
potentially abolishes this interaction. A modeling study of a
His mutation at this position has been reported and proposes
a gauche+ rotamer (1  −60°) with a 2 value of ±90°
(Banta and Anderson 2002). This set of conformations rep-
resents a commonly observed rotamer distribution (∼42%)
of His side chains, and, in the 2,5-DKGRA structure, results
in an edge-to-face ring interaction between the introduced
His side chain and the adenine ring of the bound cofactor.
The His/adenine ring interaction has been suggested as a
possible basis for improved NADH binding, and is sup-
ported by the observation that aromatic residues substituted
at this position generally result in increased NADH-medi-
ated catalysis by 2,5-DKGRA (although only the His mu-
tation retains substantial activity with NADPH as cofactor;
Banta and Anderson 2002). The structural details of the
F22Y/K232G/R238H/A272G 2,5-DKGRA mutant reported
here show that the introduced His side chain adopts a
gauche+ rotamer, but with a 2 value of +161° (Fig. 1). This
rotamer is less frequently observed (∼7%), and, in the 2,5-
DKGRA structure, allows a face-to-face stacking interac-
tion with the adenine ring of the NADH cofactor. This His
Table 2. Thermodynamic parameters for wild-type and F22Y/K232G/R238H/A272G 2,5-DKGRA
determined from isothermal (298K) equilibrium denaturation monitored using CD spectroscopy
Protein
G0
(kJ/mole)
m-value
(kJ/mole M)
Cm
(M)
Ga
(kJ/mole)
Wild type 33.5 ± 0.4 32.8 ± 0.3 1.02 ± 0.01 —
F22Y/K232G/R238H/A272G 36.4 ± 0.3 31.9 ± 0.5 1.18 ± 0.01 −5.2
a G  (CmWT − Cm mutant) * (mWT + mmutant)/2 (Pace and Scholtz 1997). A negative value for G indicates
a more stable mutant. All errors are listed as standard error of multiple data sets.
Figure 3. Fraction of the unfolded state as a function of GuHCl denatur-
ant, as determined from isothermal equilibrium denaturation data moni-
tored by CD, for wild-type 2,5-DKGRA (filled circles) and the F22Y/
K232G/R238H/A272G 2,5-DKGRA mutant (open circles). The solid line
shows the fit to the two-state model in each case.
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rotamer subsequently positions the side chain N1 atom at
the former Arg C location (Fig. 1). In the holo wild-type
2,5-DKGRA structure, the cofactor AOP1 oxygen (i.e., one
of the 2 phosphate oxygens) to Arg 238 C distance is a
close 3.1 Å (Khurana et al. 1998). Thus, the introduced His
side chain, in adopting a face-to-face stacking interaction,
also positions its side chain N1 atom in ideal juxtaposition
to form a novel charged hydrogen bond interaction with the
2 phosphate of a bound NADPH cofactor.
The observed ring stacking interaction between the intro-
duced His side chain at position 238 and the NADH adenine
ring should also provide a similar stabilizing interaction
with the NADPH cofactor. Thus, the combination of the
K232G and R238H mutations, and their effects upon
NADH or NADPH cofactor binding, can be summarized as
follows: NADPH binding has lost two electrostatic interac-
tions involving the 2 phosphate (with Lys 232 N and Arg
238 N1) but has gained an electrostatic interaction with His
238 N1; furthermore, it has gained a stacking interaction
between the adenine ring and His 238 side chain. NADH
binding has gained a stacking interaction between the ad-
enine ring and His 238 side chain. Thus, the kinetic studies
of Banta (Banta et al. 2002c), indicating that this mutation
has improved enzymatic activity with NADH and that it
retains a unique ability to function to a significant extent
with NADPH, are explained by the X-ray structural data
presented here.
The atoms of the bound NADH cofactor in the F22Y/
K232G/R238H/A272G 2,5-DKGRA mutant structure have
an average thermal factor of 50 Å2, whereas the atoms of the
NADPH cofactor bound in the wild-type structure have an
average thermal factor of 20 Å2. As previously mentioned,
the Wilson B factor value is essentially identical between
the two data sets, and the average main chain B factors for
the mutant are 18.3 Å2 in comparison to 16.3 Å2 for the
wild-type apo structure. Although the average thermal fac-
tor value of the NADH cofactor is higher in the mutant
structure, certain atoms of the cofactor exhibit thermal fac-
tors characteristic of the NADPH cofactor bound in the
wild-type structure. In particular, the adenine base, the py-
rophosphate AO1 oxygen, the NO2* oxygen of the nicotin-
amide ribose, as well as the NO7 oxygen and NN7 nitrogen
of the nicotinamide, all exhibit thermal factors similar to the
NADPH cofactor bound within the wild-type structure (Fig.
4). Conversely, the greatest increases in thermal factors are
observed within the adenine ribose moiety (Fig. 4). With the
exception of the 2 phosphate, this ribose group hydrogen
bonds exclusively with solvent (Khurana et al. 1998), and
the increase in thermal factors is likely a direct consequence
of the elimination of the 2 phosphate and the associated
interactions with enzyme. The increase in the ribose thermal
factors propagates along the length of the cofactor, with the
exception of the apparent “anchor points” listed above (Fig.
4). The introduction of the Arg 238 → His mutation has, to
a large degree, resulted in the retention of wild-type thermal
factors for the cofactor adenine (despite the loss of the ad-
jacent phosphate moiety; Fig. 4). In the wild-type structure,
the cofactor AO1 oxygen participates in a charged hydrogen
bond interaction with the main chain amide of Lys 232
(Khurana et al. 1998), and the stereochemistry of this inter-
action is maintained despite the Gly mutation at this posi-
tion. The NO1 and NO2 oxygens, located within the second
phosphate of the central pyrophosphate, also hydrogen bond
primarily with solvent and exhibit an increase in thermal
Figure 4. Relaxed stereo diagram of the NADPH cofactor bound within wild-type 2,5-DKRA (Khurana et al. 1998; left) and the
NADH cofactor bound within the F22Y/K232G/R238H/A272G 2,5-DKGRA mutant structure reported here. The colors of the atoms
indicate the relative values of the thermal factors (blue is low, red is high). Both structures are rendered on the same color scale. The
orientation of the cofactors is the same as in Figures 1 and 2.
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factors (Fig. 4). The NO2* oxygen within the nicotinamide
ribose is involved in a charged hydrogen bond interaction
with the side chain of Asp 45. This interaction is maintained
in the mutant structure. The nicotinamide NO7 oxygen and
NN7 nitrogen form interactions with Asn 140, Ser 139, and
Gln 161, and these are conserved in the mutant structure, as
is a ring-stacking interaction with the side chain of Trp 187.
Finally, the adenine ring exhibits thermal factors similar to
the NADPH bound in the wild-type structure and hydrogen
bonds through its AN6 and AN7 nitrogens to the side chains
of Asn 242 and Glu 241 (both conserved in the mutant
structure).
The 2 phosphate appears to provide key interactions that
contribute to the ordered positioning of the majority of at-
oms comprising the cofactor. Penning and coworkers have
demonstrated that in 3-	-hydroxysteroid dehydrogenase the
“anchoring” of the 2 phosphate of NADPH, by an Arg
residue equivalent to Arg 238, is necessary for pre–steady-
state kinetic transients to be observed upon NADPH binding
(Ratnam et al. 1999). The results of the thermal factor
analysis reported here suggest that anchoring of the phos-
phate is key for positional ordering throughout the length of
the cofactor (mediated through the adenine ribose), and that
it is not enough to simply maintain interactions with the
adenine moiety. Thus, in the absence of the 2 phosphate,
secondary binding interactions may need to be introduced
throughout the length of the cofactor for optimum utiliza-
tion of NADH as cofactor.
Xylose reductase (XR) is a member of a related family of
aldo-keto reductases that is able to utilize both NADH and
NADPH as a cofactor in the reduction of the open-chain
form of D-Xylose to the corresponding polyol xylitol (Lee
1998). The crystal structures of XR in complex with either
NADPH or NADH have recently been reported (Kavanagh
et al. 2002, 2003). The ability of XR to efficiently bind
NADH cofactor is due to conformational changes of two
local loops that permit novel hydrogen bonding interactions
with the 2 and 3 hydroxyl groups of the cofactor adenosine
ribose. These interactions involve side chains Glu 227 and
Asn 276 (numbering scheme of XR), with Glu 227 identi-
fied as the most significant interaction (Kavanagh et al.
2003). Glu 227 in XR is located within a short 	-helix that
has no corresponding structural element in 2,5-DKGRA.
The residue in 2,5-DKGRA that is structurally equivalent to
Asn 276 in XR is Val 234, which has no potential to par-
ticipate in hydrogen bonding interactions. Furthermore, the
ribose group in the NADH cofactor bound to XR adopts a
3-endo conformation, and not the 2-endo conformation
seen in the NADH bound to 2,5-DKGRA (or in NADPH
cofactor bound to XR and 2,5-DKGRA). Thus, the interac-
tions that facilitate NADH binding in the F22Y/K232G/
R238H/A272G 2,5-DKGRA mutant represent a uniquely
different solution to the efficient utilization of NADH co-
factor. However, both the F22Y/K232G/R238H/A272G
2,5-DKGRA mutant and XR structures highlight the impor-
tance of interactions with the adenine ribose.
The relatively low thermal stability of both 2,5-DGRA
and B has two important implications in the industrial ap-
plication for vitamin C production. The fermentation or bio-
reactor temperatures must be kept below the melting tem-
perature of the enzymes involved. In the case of 2,5-
DKGRA (the more stable of the two Corynebacterium
enzymes) the reported melting temperature is 38°C. Thus, at
a temperature typical of enteric bacterial fermentation, ap-
proximately half the population of enzyme molecules will
be denatured and inactive. The presence of irreversible path-
ways from the denatured state (e.g., aggregation or prote-
olysis) will result in a continual and rapid decline in effec-
tive enzyme activity. Secondly, low thermal stability trans-
lates to a limited tolerance for any mutagenic changes that
will further destabilize the enzyme. With regard to desired
mutations, 2,5-DKG has never been identified as a metabo-
lite in Corynebacterium; furthermore, the active site appears
to be substantially larger than the 2,5-DKG substrate
(Khurana et al. 2000). Thus, although 2,5-DKGRA and B
can stereospecifically reduce 2,5-DKG to 2-KLG, 2,5-DKG
may not represent the natural substrate within the cell.
Coupled with the relatively high Km for 2,5-DKG, these
facts suggest that the active site might be mutated to im-
prove binding or catalysis with 2,5-DKG (Powers 1996;
Khurana et al. 2000). However, if such mutations destabi-
lize the protein further, the effective enzymatic activity
could be substantially reduced, or the protein may not fold
at all. In this regard, the data in Table 2 present some rather
good news. The thermodynamic results show that the F22Y/
K232G/R238H/A272G 2,5-DKGRA mutant is also more
stable and can, therefore, be expected to exhibit greater
effective activity at elevated temperatures in comparison to
wild type. The added stability also identifies this mutant as
an appropriate background for future mutagenesis studies.
Materials and methods
Crystallization of F22Y/K232G/R238H/A272G
2,5-DKGRA in complex with NADH
The construction, expression, and purification of F22Y/K232G/
R238H/A272G 2,5-DKGRA have previously been described
(Powers 1996; Banta et al. 2002c). The purified protein was con-
centrated to 10 mg/mL in 25 mM Tris-HCl (pH 7.5) for crystal-
lization, with the addition of NADH cofactor to a concentration of
1 mM. Crystallization trials were set up using the hanging drop
vapor diffusion method (Jancarik and Kim 1991) with Hampton
Crystal Screen I and II kit solutions (Hampton Research) at room
temperature. Hanging drops contained a 1:1 mixture of protein and
crystallization buffer (5 
L each) and vapor diffused against 1 mL
reservoirs of crystallization buffer. Thin, plate-shaped crystals
grew from 1.5 M lithium sulfate and 0.1 M Na HEPES (pH 7.5)
within 7–10 d.
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Data collection and processing
Two crystals (each approximately 0.2 × 0.3 × 0.05 mm) were
mounted on a cryo loop (Hampton Research) and X-ray diffraction
data were collected at low temperature (103K). No additional cryo-
protectant was added to the crystallization buffer for protection
against ice formation. Data collection was performed for the first
crystal using a Rigaku RU-H2R rotating anode X-ray source (40
kV, 100 mA, graphite monochromatic CuK	 radiation; Rigaku
MSC) equipped with Osmic Blue confocal mirrors (MarUSA) and
an R-Axis IIc imaging plate system. Data collection for the second
crystal was accomplished using a similar X-ray source equipped
with Osmic Purple confocal mirrors and a MarCCD 165 detector.
Both crystals diffracted to approximately 1.9 Å resolution, and
indexing suggested a monoclinic C2 unit cell with dimensions
a  111.95 Å, b  55.24 Å, c  51.54 Å, and unique angle
 111.7°. The diffraction data from each crystal were combined
to achieve maximum redundancy, completeness, and signal-to-
noise ratio for a 2.0 Å data set. Data were processed using the
DENZO software program (Otwinowski 1993; Otwinowski and
Minor 1997).
Molecular replacement
Based on a molecular mass of approximately 29,000 D (Sonoyama
and Kobayashi 1987) one molecule in the asymmetric unit yielded
a Matthews coefficient (Vm) of 2.2 Å3/D, suggesting that a single
molecule represented the contents of the asymmetric unit (Mat-
thews 1968). Molecular replacement was attempted using the re-
fined 2.1 Å crystal structure of 2,5-DKGRA in complex with
NADPH (Khurana et al. 1998) as a search model (PDB accession
number 1A80; space group P21). The NADPH cofactor and sol-
vent were omitted from the search model. Rotation and translation
function searches were attempted using the MRCHK software
package (Zhang and Matthews 1994). A rotation function search,
using data from 7.0Å to 2.3 Å, resulted in a top solution with a signal
of 5.8 (next nearest peak 1.8). The correctly rotated model was
used for a subsequent translation function search in space group
C2. This search resulted in a top peak of 5.4, with the next
highest peak at 4.3. The applied rotation and translation solutions
resulted in an initial value for Rcryst of 49.9%, using all data from
27.0 Å to 3.5 Å. Rigid body refinement of the model resulted in a
slight improvement of Rcryst to 48.8%. At this point, 10% of the
data were separated for calculation of Rfree (Brunger 1992).
Refinement
The structure was refined using the TNT least-squares refinement
package (Tronrud et al. 1987; Tronrud 1992, 1996). An initial
round of individual atomic position refinement, using data from
40.0 Å to 3.0 Å improved Rcryst to 37.2% (Rfree to 39.0%) while
maintaining excellent stereochemistry. Inspection of the 2Fo-Fc
electron density map for the entire structure indicated that several
residue positions were in the incorrect rotamer and required re-
building. These residues of the model were, therefore, deleted prior
to subsequent rounds of refinement. Manual model building was
performed using 2Fo-Fc, and Fo-Fc omit maps and the molecular
graphics program O (Jones et al. 1991). Individual atomic coordi-
nate refinement was performed in stages using data out to 2.5 Å
resolution, at which point atomic thermal factors were simulta-
neously refined using a correlated thermal factor restraint library
(Tronrud 1996). With the inclusion of all data to 2.0 Å, solvent
molecules were added to the structure if they exhibited well-de-
fined density in both the 2Fo-Fc and Fo-Fc electron density maps,
appropriate hydrogen bonding stereochemistry with neighboring
groups, and refined thermal factors of 60 Å2 or better. At this point
in the refinement the density for the NADH cofactor was unam-
biguous and the NADH molecule was added to the structure. All
coordinate and structure factor files have been deposited in the
protein data bank (1M9H).
Isothermal equilibrium denaturation
Purified mutant protein was dialyzed against 10 mM sodium phos-
phate (pH 7.0) and concentrated to approximately 1 mM. Ther-
mally induced denaturation of 2,5-DKGRA results in irreversible
aggregation (Powers 1996), and accurate thermodynamic param-
eters cannot be determined. For this reason, isothermal equilibrium
denaturation was utilized. Isothermal equilibrium denaturation was
quantitated using CD spectroscopy and guanidine hydrochloride
(GuHCl) as a denaturant. GuHCl was prepared as a 7.9 M stock
solution (determined by refractive index) in 10 mM phosphate
buffer (pH 7.0). Protein samples (at a final concentration of 10

M) were allowed to equilibrate with GuHCl (0 M–2 M with
0.1-M increments) by overnight incubation at 4°C. CD measure-
ments were carried out with an AVIV 202 circular dichroism spec-
trometer (AVIV), fitted with a thermoelectric cuvette holder, and
interfaced with a model CTF-33 refrigerated recirculator bath
(Thermo NESLAB) maintained at 298K. Isothermal CD spectra
were acquired by scanning from 260 nm down to 200 nm in 1-nm
increments with 1 nm bandwidth. Duplicate scans were recorded
for each protein sample; triplicate experiments were collected and
averaged. Buffer traces were subsequently subtracted from protein
scans. The general purpose nonlinear least squares fitting program
DataFit (Oakdale Engineering) was used to fit the CD signal ver-
sus GuHCl concentration to a six-parameter two-state model (Eft-
ink 1994):
F = F0N + SND + F0D + SDDe−G0+(m[D]))RT
1 + e−G0+(m[D]))RT (1)
where the denaturant concentration is given by [D], the native state
(0 M denaturant) CD signal intercept and slope are F0N and SN,
respectively, the denatured state CD signal intercept and slope are
FOD and SD, respectively, and the free energy of unfolding func-
tion intercept and slope are G0 and m, respectively. G0 and m
describe the linear function of the unfolding free energy versus
denaturant concentration under isothermal equilibrium conditions.
The effect of mutation upon the stability of the protein (G) was
calculated using the method of Pace and Sholtz (1997):
G = Cm WT − Cm mutant * mWT + mmutant2 (2)
where Cm WT and Cm mutant are the denaturant concentrations for
the midpoint of the isothermal denaturation (G  0) for wild-
type and mutant 2,5-DKGRA, respectively, and mWT and mmutant
refer to the m values relating G as a function of denaturant
concentration for the wild-type and mutant protein, respectively. In
this case, a negative value for G indicates the mutant is stabi-
lized in comparison to the wild type.
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